“High-quality artificial intelligence-generated images preserve vital information from raw PET images without the additional radiation exposure from CT scans,” experts involved in the study explained.

The company’s CEO, Greg Piefer, detailed the plans at the Wisconsin Entrepreneurs’ Conference on June 2, stating that production would be achieved via small-scale nuclear transmutation.

The work of a chemistry professor at the University of Wisconsin-Milwaukee is helping to blaze the trail of reducing the United States’ dependence on foreign countries for vital medical isotopes. 

The study, which followed 195 patients recently diagnosed with multiple myeloma (MM), found that a negative PET/CT scan six months after diagnosis and induction therapy was significantly linked with improved survival.

The new equipment, which initially will be used to treat prostate and neuroendocrine tumors, is expected to be operational in July.

In pediatric care settings, hybrid PET/MR imaging combines “exquisite soft-tissue information obtained by MR imaging with functional information provided by PET.”

The FDA has approved a lab test for evaluating cognitively impaired adults who may be in the early stages of Alzheimer’s disease.

The findings could help clinicians manage patients’ treatment when the origin of axillary lymphadenopathy is of concern, experts suggested.